Croma PolyPhil Hair 1x2ml
Important Notice
Regulated medical device (EU MDR 2017/745). For sale exclusively to qualified healthcare professionals.
What this purchase includes
- Original productFrom the manufacturer or an official distributor, CE marked.
- Batch and expiry documentedRecorded per unit on the delivery note and the invoice.
- Controlled storageOur own Madrid warehouse, 12 to 18 °C under 24 h control.
- Dispatch in 24 to 48 hFrom Madrid, insured and with a tracking number.
- Reachable Monday to Friday9:00 to 17:00 by WhatsApp and email. People, not forms.
Croma PolyPhil™ Hair is the variant of Croma-Pharma's polynucleotide range intended for the scalp: 15 mg of PN-HPT® in a 2 ml syringe. It shares its concentration with PolyPhil Eye, but its indication is different — revitalisation of the follicular environment — and its protocol is the most extensive in the range.
- PN-HPT® 15 mg / 2 ml
- Hyaluronic acid not contained
- Contents 1 syringe × 2 ml
- Needles 2 × 30G ½"
- Dose 2 ml per session
Composition and technology
- PN-HPT® polynucleotides: 15 mg per 2 ml syringe (7.5 mg/ml), obtained from freshwater trout from controlled European aquaculture, with full traceability of the production chain.
- PN-HPT® (Polynucleotide High Purification Technology): Croma's proprietary purification process, which guarantees a high degree of purity of the polynucleotide chain.
- Mechanism of action: the polynucleotides stimulate fibroblast proliferation and the neosynthesis of collagen and elastin, retain water and act as free-radical scavengers. In the scalp the objective is to improve the perifollicular dermal environment.
- Without hyaluronic acid and without anaesthetic.
Position within the PolyPhil range
| PolyPhil | PN-HPT® 40 mg / 2 ml, without HA — face, neck, décolletage, hands, scars |
|---|---|
| PolyPhil Next | PN-HPT® 20 mg + HA 20 mg / 2 ml — mature and dehydrated skin, mid third of the face, scars and acne scars |
| PolyPhil Eye | PN-HPT® 15 mg / 2 ml — eye contour, eyelids, superficial lines |
| PolyPhil Hair | PN-HPT® 15 mg / 2 ml — scalp and eyebrows |
Note: the PhilArt line was renamed PolyPhil™ in 2024/2025. It is the same product and the same formulation.
Indications and treatment areas
- Scalp: frontal area, temporal recessions, hairline and vertex
- Eyebrows
The manufacturer positions the product in the management of weakened hair and female pattern hair loss. It is not a medicinal product: it acts as a conditioner of the dermal tissue, does not replace pharmacological treatments for alopecia and should be indicated after the relevant diagnosis.
Technique and treatment protocol
- Injection plane: intradermal, in the scalp.
- Technique: multiple puncture with microdeposits distributed over the area to be treated.
- Recommended needle: 30G ½" (13 mm), 2 units included.
- Dose: 2 ml per session.
- Loading protocol: 4 sessions at intervals of 7 to 14 days.
- Maintenance: 4 further sessions at intervals of 21 days.
- Apply on a clean scalp. The binding protocol is that of the instructions for use.
Technical data
| Manufacturer | Croma-Pharma GmbH, Austria |
|---|---|
| Active substance | PN-HPT® polynucleotides 15 mg per 2 ml syringe (7.5 mg/ml) |
| Origin of the polynucleotides | Freshwater trout, controlled European aquaculture |
| Presentation | 1 pre-filled syringe of 2.0 ml |
| Needles | 2 × 30G ½" (13 mm) |
| Application plane | Intradermal (scalp) |
| Classification | Medical device with CE marking 0373 |
| Use | Qualified healthcare professionals only |
Storage and pack contents
- Storage: between 2 °C and 25 °C, in a dry place protected from sunlight. Do not freeze.
- Do not use after the expiry date shown on the pack.
- Single-use product. Do not reuse or re-sterilise.
- The pack contains: 1 pre-filled syringe of 2 ml, 2 needles 30G ½", user information and traceability labels.
Contraindications and warnings
Known hypersensitivity to any of the components; pregnancy and breastfeeding; active autoimmune diseases or a history of them; active infection or inflammation of the scalp in the treatment area; coagulation disorders; epilepsy; circulatory disorders; ongoing antibiotic or oncological treatment; patients under 18 years of age.
Always consult the instructions for use included in the pack before application. The binding contraindications are those set out in the official documentation accompanying the product.
Medical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Croma-Pharma. This data sheet does not replace the instructions for use accompanying the product.